Source: International Congress 2018 – Clinical markers of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Alahmadi (Manchester, United Kingdom), A. Simpson (Hull, United Kingdom), C. Gomez (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), D. Shaw (Nottingham, United Kingdom), L. Fleming (London, United Kingdom), G. Roberts (Southampton, United Kingdom), J. Riley (London, United Kingdom), S. Bates (London, United Kingdom), A. Sousa (London, United Kingdom), R. Knowles (Stevenage, United Kingdom), A. Bansal (Cambridge, United Kingdom), J. Corfield (Mölndal, Belgium), I. Pandis (London, United Kingdom), K. Sun (London, United Kingdom), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Marseille, France), B. DahléN (Stockholm, Sweden), I. Horvath (Budapest, Hungary), N. Krug (Hannover, Germany), P. Montuschi (Milan, Italy), T. Sandstrom (Umeå, Sweden), F. Singer (Bern, Switzerland), S. Wagers (Maasmechelen, Belgium), I. Adcock (London, United Kingdom), R. Djukanovic (Southampton, United Kingdom), K. Chung (London, United Kingdom), P. Sterk (Amsterdam, Netherlands), S. Dahlen (Stockholm, Sweden), S. Fowler (Manchester, United Kingdom). Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort. 3992

Member's Comments

No comment yet.

Related content which might interest you: Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma Source: Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019 Year: 2020 Oral corticosteroid use in Swedish and Finnish severe asthma patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019 Year: 2020 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Maintenance and reliever combination budesonide/formoterol therapy in asthma patients at risk of severe exacerbations: A randomised controlled trial Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study Source: Annual Congress 2010 - Management of airway disease Year: 2010 Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Control of persistent asthma patients on inhaled corticosteroids in a real-life setting Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010 Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Impact of omalizumab in patients with severe asthma Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Impact of add-on medications on patient‘s satisfaction in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 273s Year: 2005 Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis Source: Eur Respir J 2005; 26: Suppl. 49, 49s Year: 2005 The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Antibiotics use for asthma exacerbation in Japanese geriatric patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Adherence to medication, mortality and severe exacerbations in the TORCH study Source: Annual Congress 2008 - COPD Year: 2008